MGIM
MRNA icon

M&G Investment Management’s Moderna MRNA Stock Holding History

M&G Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-996
Closed -$253 – 495
2021
Q4 		$253 Sell
996
-11,556
-92% -$3.38M ﹤0.01% 443
2021
Q3 		$4.83K Buy
12,552
+11,483
+1,074% +$4.23M 0.01% 418
2021
Q2 		$251 Buy
+1,069
New +$191K ﹤0.01% 710

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

M&G Investment Management's MRNA Position: Q1 2022 in Review

M&G Investment Management sold out of Moderna (MRNA) in Q1 2022, closing a stake of 996 shares — an estimated $253 sold.

M&G Investment Management first reported a position in MRNA in Q2 2021 and held it in 3 quarters. The position peaked at $4.83K in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • M&G Investment Management reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • M&G Investment Management sold 996 Moderna shares in Q1 2022, an estimated $253.
  • M&G Investment Management first reported a position in Moderna in Q2 2021 and held it in 3 quarters.
  • M&G Investment Management's Moderna position peaked at $4.83K in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on M&G Investment Management's 13F filing for Q1 2022, filed 13 May 2022.